In a recent report by
Transparency Market Research, the cell culture market is rapidly
being adopted in the field of pharmaceuticals. Companies managing the global
cell culture market are more focused on increasing strategic collaborations and
expanding product development worldwide. Furthermore, they are aiming at
expanding their footprints in emerging markets such as Latin America and Asia
Pacific. An example of such collaboration would be the announcement of
collaboration of Valneva SE and GE Healthcare in Nov, 2016 which optimized
virus productivity in Valneva’s EB66 cell line. Furthermore, the inauguration
of EX-CELL Advanced HD perfusion mediums, is expected to help strengthen the
streamline and production of regulatory compliances.
According to TMR, Thermo
Fisher Scientific Inc., Dickinson and Company, GE Healthcare, Sartorius AG, and
Lonza are some of the leading companies operating in the market. The position
in the market is established by leading players and they are enjoying brand
loyalty among customers. These manufacturers have extensive distribution
network across the world and offer a wide variety of product range. On the back
of these factors, they enjoy a stronghold in the global cell
culture market.
According to TMR report,
the global cell culture market is expected to register a 9.5% CAGR during the
forecast period of 2017 to 2025. The valuation of 2016 was around US$13.00 bn
and is anticipated to remain stable by the end of the forecast period. Owing to
increased focus on Research and Development activities, and the development of
healthcare sector and high unmet clinical needs in the region, the cell culture
market is expanding with 10.0% CAGR in Asia Pacific.
Request a PDF Sample
- https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=405
Increase Use of
Stem-Cell Structure to Boost Market
Stem cell culture aids in
the stabilization of manufacturing of drugs and allows to produce a wide
variety of cell lines and its related products. There is a high potential for
growth of the cell culture market with applications like stem cell research in
the years to come. Stem cell therapies serve to treat the cause of the disease
whereas the old time pharmaceutical therapeutics could only aid in treating the
symptoms of the disease. Thus, there is high prospect for the global cell
culture market in the field of stem cell culture for developing drugs.
Cell structure is
considered one of the most important steps in biosimilar production for antibodies.
Cell structure reduces manufacturing cost and also increases the productivity
and efficiency of biosimilar antibodies.
A majority of
manufacturers are persistently trying to expand their product portfolio by
launching new and advanced system for large-scale production. This involves
both low risk of contamination and is cost-effective providing a win-win
situation for the manufacturers.
Strict Regulatory
Framework and High Quality Standards Restricting Growth
The imposition of solid
regulatory framework and high quality standards set by market leaders may limit
the speed of market perforation by newcomers. Furthermore, ethical issues
corresponding to the use of high cost of infrastructure, stringent regulations,
and fetal bovine serum required for cell culture are expected to hinder the
market during the forecast period.
However, there is
increase in scope for the use of cell culture in biologics as the research and
development in biopharmaceuticals field concentrates on the discovery of new
therapeutics for new mechanisms of drug action and rare diseases. Owing to the
treatment of chronic diseases in both developing as well as developed
countries, there is an increase in demand for cost-effective and efficient products.
With this, the demand for approval of biosimilar products have also raised. Due
to the rise in demand, the global cell culture market is anticipated to provide
lucrative opportunities in the course of the forecast period.
This review is based on
the findings of a TMR report titled,” Cell Culture Market (Product -
Instruments (Cell Culture Vessels (Bioreactors), Carbon Dioxide Incubators,
Biosafety Cabinets, Cryogenic Tanks), Mediums (Chemically Defined Mediums,
Classical Mediums, Lysogeny Broths, Serum-free Mediums, Protein-free Mediums,
Specialty Mediums), Sera, Reagents (Growth Factors & Cytokines, Albumin,
Protease Inhibitors, Thrombin, Attachment Factors, Amino Acids); End use -
Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, and
Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends,
and Forecast 2017 - 2025.”
More Trending
Reports by Transparency Market Research:
About Us
Transparency Market
Research is a next-generation market intelligence provider, offering fact-based
solutions to business leaders, consultants, and strategy professionals.
Our reports are
single-point solutions for businesses to grow, evolve, and mature. Our
real-time data collection methods along with ability to track more than one
million high growth niche products are aligned with your aims. The detailed and
proprietary statistical models used by our analysts offer insights for making
right decision in the shortest span of time. For organizations that require
specific but comprehensive information we offer customized solutions through ad
hoc reports. These requests are delivered with the perfect combination of right
sense of fact-oriented problem solving methodologies and leveraging existing
data repositories.
TMR believes that unison
of solutions for clients-specific problems with right methodology of research
is the key to help enterprises reach right decision.
Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com